Valuation: Organoidsciences Ltd.

Market Cap 49.59B 35.59M 30.48M 28.43M 26.09M 49.03M 3.41B 49.99M 337M 131M 1.71B 134M 131M 5.65B P/E 2024 *
-
P/E 2025 -15.2x
Enterprise Value 38.03B 27.3M 23.37M 21.8M 20.01M 37.6M 2.61B 38.34M 259M 101M 1.31B 102M 100M 4.33B EV / Sales 2024 *
-
EV / Sales 2025 99.9x
Free-Float
57.27%
Yield 2024 *
-
Yield 2025 -
1 day+0.40%
1 week-10.46%
Current month+1.35%
1 month+2.17%
3 months-53.23%
6 months-75.35%
Current year-80.34%
1 week 7,450
Extreme 7450
8,580
1 month 6,070
Extreme 6070
9,260
Current year 6,070
Extreme 6070
39,200
1 year 6,070
Extreme 6070
48,500
3 years 6,070
Extreme 6070
52,000
5 years 6,070
Extreme 6070
52,000
10 years 6,070
Extreme 6070
52,000
Manager TitleAgeSince
Chief Executive Officer 62 2026-01-01
Chief Executive Officer 46 -
Chief Tech/Sci/R&D Officer 41 -
Director TitleAgeSince
Director/Board Member 46 -
Director/Board Member 41 -
Director/Board Member - 2025-03-26
Date Insider Type Main position Quantity % Market Cap.
5/14/25 Others

Chief Executive Officer

1,670,000 -
5/14/25 Others 30,000 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%-10.46%-74.86% - 35.53M
+1.14%+2.27%+2.38%+24.14% 50.5B
-1.36%+4.82%+485.55%+614.84% 46.01B
-2.04%+3.69%+19.34%+91.23% 42.85B
+2.72%+6.02%+33.33%+19.66% 41.03B
0.00%-3.91%+18.49%+47.98% 32.02B
-1.85%+3.48% - - 17.05B
+0.72%+5.27%+31.55%+145.37% 16.98B
+3.06%+3.88%+5.81%+35.00% 14.3B
+0.50%+3.62%+82.64%+46.53% 13.84B
Average +0.33%+1.58%+67.14%+128.09% 27.46B
Weighted average by Cap. +0.18%+2.74%+104.86%+152.88%

Financials

2024 2025
Net sales 1.95B 1.4M 1.2M 1.12M 1.03M 1.93M 134M 1.97M 13.29M 5.18M 67.23M 5.26M 5.15M 223M 2.41B 1.73M 1.48M 1.38M 1.27M 2.38M 165M 2.43M 16.37M 6.38M 82.83M 6.49M 6.34M 274M
Net income -11.25B -8.07M -6.91M -6.45M -5.92M -11.12M -772M -11.34M -76.5M -29.82M -387M -30.31M -29.65M -1.28B -15.37B -11.03M -9.44M -8.81M -8.09M -15.19M -1.06B -15.49M -105M -40.75M -529M -41.42M -40.52M -1.75B
Net Debt -8.11B -5.82M -4.98M -4.65M -4.27M -8.01M -557M -8.17M -55.14M -21.5M -279M -21.85M -21.37M -924M -11.56B -8.3M -7.11M -6.63M -6.08M -11.43M -794M -11.66M -78.64M -30.66M -398M -31.16M -30.48M -1.32B
Logo Organoidsciences Ltd.
OrganoidSciences Ltd is a Korea-based company primarily engaged in the development of regenerative therapies and provision of new material evaluation solutions. The Company primarily provides an organoid-based new material evaluation solution under the name of ODISEI to predict the effects of various new materials such as new drugs, foods and cosmetics when applied to the human body. In addition, the Company develops organoid-based regenerative therapies that directly regenerate tissues by engrafting on damaged areas. The Company is also engaged in the sale of intestinal organoid therapeutics, salivary gland organoid regenerative therapeutics, and other research reagents.
Employees
-
Date Price Change Volume
26-08-20 ₩7,530.00 +0.40% 19,920
26-08-19 ₩7,500.00 -4.21% 22,769
26-08-18 ₩7,830.00 -4.86% 21,875
26-08-14 ₩8,230.00 -2.14% 23,454
26-08-13 ₩8,410.00 -2.89% 23,738
  1. Stock Market
  2. Stocks
  3. A476040 Stock